Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687102 · ClinicalTrials.gov registry record · Phase 3
Cognition in the Study of Tamoxifen and Raloxifene
A Phase 3 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,498
- Enrollment target
NCT00687102: Completed Phase 3 study, sponsored by Wake Forest University.
NCT00687102 is a Phase 3 study that has completed, run by Wake Forest University. The registered enrollment target is 1,498 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00687102, a Phase 3 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,498 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.
Primary Outcome
Mean Change From Baseline on the Benton Visual Retention (BVRT) Test scores. Adjusted for age, ethnicity, education, and baseline measure, for participants with true baseline measures. The BVRT measures short term visual memory and visuo-constructional abilities. Each of 10 designs was presented one at a time for 10 seconds, and immediately after the design was withdrawn, the participant was instructed to draw it from memory on a blank sheet of paper. The score on the BVRT is the total number o
Interventions
- DRUG raloxifene
- DRUG tamoxifen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,498 participants |
| Start Date | 2001-10 |
| Est. Completion | 2008-03 |
| Phase | Phase 3 |
What the finished NCT00687102 record still lists
NCT00687102 is an interventional study that assigns participants to a tested intervention. Its 1,498 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% higher).
The record links to 0 conditions, and to 2 interventions - of which raloxifene is the first listed.
NCT00687102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00687102 about?
NCT00687102 is a clinical study titled "Cognition in the Study of Tamoxifen and Raloxifene". The purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.
What is the current status of trial NCT00687102?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,498 participants. The study started on 2001-10. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00687102?
The interventions under investigation include: raloxifene (DRUG), tamoxifen (DRUG).
Who is sponsoring clinical trial NCT00687102?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00687102's enrollment target sits among peer trials
1,498 163rd of 2000 higher than 1,838 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia